Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine-folic acid in hypertension and hyperhomocysteinemia
NCT01848873Phase 3Unknown
- Sponsor
- Shenzhen Ausa Pharmaceutical
- Start
- Jan 2013
- Primary completion
- Aug 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of folic acid in essential hypertension, hyperhomocysteinemia, sponsored by Shenzhen Ausa Pharmaceutical. Status: unknown.
02
Drugs
folic acid
03
Conditions
essential hypertensionhyperhomocysteinemia
Beyond the preview
Go deeper on NCT01848873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848873.